Identifying Lanthionine Ketimine Derivatives for Maturation and Proliferative Effects in Oligodendrocyte Progenitor Cells
- PMID: 40692140
- PMCID: PMC12296138
- DOI: 10.1080/17590914.2025.2535963
Identifying Lanthionine Ketimine Derivatives for Maturation and Proliferative Effects in Oligodendrocyte Progenitor Cells
Abstract
Previous studies have shown that lanthionine ketimine ethyl ester (LKE) reduces clinical scores in the experimental autoimmune encephalomyelitis (EAE) mouse model of Multiple Sclerosis, induces differentiation of oligodendrocyte progenitor cells (OPCs) in vitro, and accelerates remyelination following cuprizone induced demyelination. In a search for derivatives with greater efficacy to induce OPC maturation or proliferation, we screened a panel of 2-alkyl and 3-phosphonate substituted LK derivatives. Incubation of Oli-neu oligodendrocyte cells with 2-n-butyl- or 2-n-hexyl-LKE-phosphonate reduced spontaneous cell death, increased proliferation, and increased maturation. These were associated with changes in corresponding mRNA levels of Olig2, PLP, and O4. These derivatives also reduced cell death and increased proliferation and maturation in primary mouse OPCs. The increased hydrophobicity of these derivatives suggests these will be better candidates for testing effects in animal models of Multiple Sclerosis and other demyelinating diseases.
Keywords: Oli-neu cells; differentiation; myelin; oligodendrocyte; proliferation.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures









Similar articles
-
Lanthionine Ketimine Ethyl Ester Induces Proliferation and Maturation and Regulates Calcium Flux in Primary Mouse Oligodendrocyte Progenitor Cells.J Neurosci Res. 2025 Jul;103(7):e70061. doi: 10.1002/jnr.70061. J Neurosci Res. 2025. PMID: 40579839 Free PMC article.
-
Effects of the CRMP2 activator lanthionine ketimine ethyl ester on oligodendrocyte progenitor cells.J Neuroimmunol. 2019 Sep 15;334:576977. doi: 10.1016/j.jneuroim.2019.576977. Epub 2019 Jun 3. J Neuroimmunol. 2019. PMID: 31177034
-
ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.FASEB J. 2021 Mar;35(3):e21431. doi: 10.1096/fj.202002465R. FASEB J. 2021. PMID: 33595155 Free PMC article.
-
Cell therapy procedure using anti-inflammatory macrophage M2 can potentially reduce Clinical Score in animals with Experimental Autoimmune Encephalomyelitis: A preclinical systematic review and meta-analysis study.Fundam Clin Pharmacol. 2023 Apr;37(2):215-225. doi: 10.1111/fcp.12844. Epub 2022 Nov 14. Fundam Clin Pharmacol. 2023. PMID: 36300567
-
Factors Regulating Oligodendrocyte Progenitor Cell Migration: From Development to Remyelination.Glia. 2025 Oct;73(10):1951-1966. doi: 10.1002/glia.70051. Epub 2025 Jun 13. Glia. 2025. PMID: 40509888 Review.
References
-
- Arimura, N., Ménager, C., Kawano, Y., Yoshimura, T., Kawabata, S., Hattori, A., Fukata, Y., Amano, M., Goshima, Y., Inagaki, M., Morone, N., Usukura, J., & Kaibuchi, K. (2005). Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Molecular and Cellular Biology, 25(22), 9973–9984. 10.1128/MCB.25.22.9973-9984.2005 - DOI - PMC - PubMed
-
- Boccazzi, M., Macchiarulo, G., Lebon, S., Janowska, J., Le Charpentier, T., Faivre, V., Hua, J., Marangon, D., Lecca, D., Fumagalli, M., Mani, S., Abbracchio, M. P., Gressens, P., Schang, A. L., & Van Steenwinckel, J. (2023). G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation. Neurobiology of Disease, 187, 106315. 10.1016/j.nbd.2023.106315 - DOI - PubMed
-
- de Faria, O., Jr., Dhaunchak, A. S., Kamen, Y., Roth, A. D., Kuhlmann, T., Colman, D. R., & Kennedy, T. E. (2019). TMEM10 promotes oligodendrocyte differentiation and is expressed by oligodendrocytes in human remyelinating multiple sclerosis plaques. Scientific Reports, 9(1), 3606. 10.1038/s41598-019-40342-x - DOI - PMC - PubMed
-
- Dupree, J. L., Paez, P. M., Tiwari-Woodruff, S. K., Denton, T. T., Hensley, K., Angeliu, C. G., Boullerne, A. I., Kalinin, S., Egge, S., Cheli, V. T., Denaroso, G., Atkinson, K. C., Feri, M., & Feinstein, D. L. (2022). Lanthionine ketimine ethyl ester accelerates remyelination in a mouse model of multiple sclerosis. ASN Neuro, 14(1), 17590914221112352. 10.1177/17590914221112352 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous